Alzheimer’s Network for Treatment and Diagnostics. Observational study for patients who are being treated with Novel FDA approved therapies.
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease.
Initiation of Lecanemab in Early Alzheimer's Disease Using a Subcutaneous Autoinjector: A Multicenter, Prospective, Non-Interventional, Real-World Study Evaluating Treatment Experience, Safety, and Clinical Implementation.
A Study of Remternetug Versus Placebo in Early Alzheimer’s Disease Participants at Risk for Cognitive and Functional Decline
A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY STUDY OF TRONTINEMAB IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE(MCI TO MILD DEMENTIA DUE TO AD)
